These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11377616)

  • 21. Pharmacogenetics/genomics and personalized medicine.
    Sadée W; Dai Z
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer.
    Nagar S; Remmel RP
    Oncogene; 2006 Mar; 25(11):1659-72. PubMed ID: 16550166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying the genome to national drug formulary policy in the developing world.
    Roederer MW; McLeod HL
    Pharmacogenomics; 2010 May; 11(5):633-6. PubMed ID: 20415551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics: from description to prediction.
    Weber WW
    Clin Lab Med; 2008 Dec; 28(4):499-511. PubMed ID: 19059058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline pharmacogenetics of paclitaxel for cancer treatment.
    Hertz DL
    Pharmacogenomics; 2013 Jul; 14(9):1065-84. PubMed ID: 23837481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the value of haplotype-based genotype-phenotype analysis and on data transformation in pharmacogenetics and -genomics.
    Vormfelde SV; Brockmöller J
    Nat Rev Genet; 2007 Dec; 8(12):. PubMed ID: 19066603
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacogenetics: current state after 30 years of research].
    Eichelbaum M
    Dtsch Med Wochenschr; 2013 Mar; 138(13):659-61. PubMed ID: 23512369
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacogenetics and nicotine addiction treatment.
    Munafò MR; Shields AE; Berrettini WH; Patterson F; Lerman C
    Pharmacogenomics; 2005 Apr; 6(3):211-23. PubMed ID: 16013953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Goals of pharmacogenetics for predetermined therapy. With genetic record to the doctor].
    Eiden P
    MMW Fortschr Med; 2000 Aug; 142(31-32):4-6. PubMed ID: 10992758
    [No Abstract]   [Full Text] [Related]  

  • 30. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.
    Ansari M; Krajinovic M
    Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer pharmacogenetics: polymorphisms, pathways and beyond.
    Ulrich CM; Robien K; McLeod HL
    Nat Rev Cancer; 2003 Dec; 3(12):912-20. PubMed ID: 14740638
    [No Abstract]   [Full Text] [Related]  

  • 33. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.
    Milek M; Murn J; Jaksic Z; Lukac Bajalo J; Jazbec J; Mlinaric Rascan I
    Pharmacology; 2006; 77(3):105-14. PubMed ID: 16691038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Context, ethics and pharmacogenetics.
    Hedgecoe AM
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):566-82. PubMed ID: 16980195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline genetic variation, cancer outcome, and pharmacogenetics.
    Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G
    J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.
    Savonarola A; Palmirotta R; Guadagni F; Silvestris F
    Pharmacogenomics J; 2012 Aug; 12(4):277-86. PubMed ID: 22760589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic considerations for late life depression therapy.
    Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
    Goetz MP; Ames MM; Weinshilboum RM
    Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacogenetics and tailored drug therapy].
    Nielsen FC; Borregaard N
    Ugeskr Laeger; 2009 Mar; 171(10):790-4. PubMed ID: 19265602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.